| 상품명칭 |
Doxazosin |
| 별명 |
DoxazosinMesylate77883-43-3/Base; DOXAZOSIN(SUBJECTTOPATENTFREE); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-; UK 33,274; UK 33274; [4-(4-Amino-6,7-dimethoxy-quinazolin-2- yl)piperazin-1-yl]-(2,5-dioxabi cyclo[4.4.0]deca-6,8,10-trien-4-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](2,3-dihydro-1,4-benzodioxin-2-yl)methanone methanesulfonate (1:1) |
| 분자식 |
C24H29N5O8S |
| 분자량 |
547.5808 |
| InChI |
InChI=1/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4) |
| cas번호 |
74191-85-8 |
| 분자 구조 |
|
| 녹는 점 |
289-290℃ |
| 비등점 |
718°C at 760 mmHg |
| 인화점 |
388°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
